Immunocore Holdings (IMCR) FCF Margin (2021 - 2026)

Immunocore Holdings has reported FCF Margin for 6 years, with the latest figure at 14.58% in Q1 2026.

• Quarterly FCF Margin fell 1473.0% year-over-year to 14.58% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 7.45% (down 1525.0% YoY) and the FY2025 annual result came in at 3.76%, down 1050.0% from the prior year.
• FCF Margin advanced to 14.58% in Q1 2026 per IMCR's latest filing, from 34.01% in the prior quarter.
• Over five years, FCF Margin peaked at 30.69% in Q2 2024 and troughed at 34.01% in Q4 2025.
• A 5-year average of 2.32% and a median of 5.39% in 2022 frame the typical range for FCF Margin.
• The sharpest annual moves came in 2022 and 2023: FCF Margin jumped 45041 bps in 2022, then sank 3708 bps in 2023.
• Over 5 years, FCF Margin stood at 10.64% in 2022, then slumped by 348 bps to 26.44% in 2023, then gained by 21 bps to 20.86% in 2024, then tumbled by 63 bps to 34.01% in 2025, then soared by 57 bps to 14.58% in 2026.
• According to Business Quant data, FCF Margin over the past three periods registered 14.58%, 34.01%, and 5.02% for Q1 2026, Q4 2025, and Q3 2025 respectively.